Prudential plc’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-9,400
| Closed | -$218K | – | 812 |
|
|
2024
Q2 | $218K | Sell |
9,400
-16,600
| -64% | -$386K | ﹤0.01% | 720 |
|
|
2024
Q1 | $626K | Buy |
26,000
+3,500
| +16% | +$84.3K | ﹤0.01% | 572 |
|
|
2023
Q4 | $524K | Sell |
22,500
-10,600
| -32% | -$247K | 0.01% | 768 |
|
|
2023
Q3 | $674K | Buy |
33,100
+4,100
| +14% | +$83.5K | 0.01% | 658 |
|
|
2023
Q2 | $674K | Hold |
29,000
| – | – | 0.01% | 701 |
|
|
2023
Q1 | $665K | Buy |
+29,000
| New | +$665K | 0.01% | 690 |
|